Lorenzo Simonelli - 04 Mar 2026 Form 4 Insider Report for Baker Hughes Co (BKR)

Signature
/s/ Fernando Contreras, Attorney-in-fact
Issuer symbol
BKR
Transactions as of
04 Mar 2026
Net transactions value
-$16,663,610
Form type
4
Filing time
06 Mar 2026, 19:12:34 UTC
Previous filing
06 Feb 2026
Next filing
10 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Simonelli Lorenzo Chairman, President and CEO, Director 575 NORTH DAIRY ASHFORD ROAD, SUITE 100, HOUSTON /s/ Fernando Contreras, Attorney-in-fact 06 Mar 2026 0001709160

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BKR Class A Common Stock Options Exercise +187,343 +25% $35.70* 945,403 04 Mar 2026 Direct F1
transaction BKR Class A Common Stock Sale $16,663,610 -272,593 -29% $61.13 672,810 04 Mar 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BKR Stock Option (Right to Buy) Options Exercise -187,343 -50% $0.000000* 187,344 04 Mar 2026 Class A Common Stock 187,343 $35.70 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.54 to $62.28, inclusive. Details on the number of shares sold at each separate price will be provided to the Issuer, any shareholder of the Issuer, or staff of the Securities and Exchange Commission upon request.
F3 The stock option was granted on August 1, 2017 and vested in three equal annual installments beginning one year from the date of grant.